Alexandra M. Nanzer - Concepedia

Author

Alexandra M. Nanzer

Also Known As

A. Nanzer, A.M. Nanzer, Alexandra M A Nanzer, Alexandra M Nanzer, Alexandra M. Nanzer, Alexandra Nanzer, Alexandra M. Nanzer

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

King's College London Asthma UK Guy's and St Thomas' NHS Foundation Trust St. James's Hospital Trinity College Dublin

About

Alexandra M. Nanzer is an author at King's College London specializing in asthma, medicine, and allergy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	707
2	Allergy	7	7	617
3	Allergy Medicine	6	6	604
4	Arts	1	1	32
5	Public Health	1	1	37

Alexandra M. Nanzer

Publications

981

Citations

H-Index

Page 1

	Year	Citations
Real-World Effectiveness of Benralizumab in Severe Eosinophilic Asthma Joanne Kavanagh, A Hearn, Jaideep Dhariwal, CHEST Journal AsthmaRheumatologyAllergyReal-world EffectivenessAllergy Medicine	2020	243
Real-World Effectiveness and the Characteristics of a “Super-Responder” to Mepolizumab in Severe Eosinophilic Asthma Joanne Kavanagh, G d’Ancona, Maria Elstad, CHEST Journal AsthmaSevere Eosinophilic AsthmaAllergyReal-world EffectivenessAllergy Medicine	2020	192
Somatostatin analogues stimulate p27 expression and inhibit the MAP kinase pathway in pituitary tumours Erika Hubina, Alexandra M. Nanzer, Matthew Hanson, European Journal of Endocrinology	2006	105
Adherence to inhaled corticosteroids and clinical outcomes in mepolizumab therapy for severe asthma G d’Ancona, Joanne Kavanagh, Cris Roxas, European Respiratory Journal	2020	84
Benralizumab Effectiveness in Severe Asthma Is Independent of Previous Biologic Use David J. Jackson, Hassan Burhan, Andrew Menzies‐Gow, The Journal of Allergy and Clinical Immunology In Practice AsthmaRheumatologyAllergyAllergy MedicineImmunology	2022	53
Use of digital measurement of medication adherence and lung function to guide the management of uncontrolled asthma (INCA Sun): a multicentre, single-blinded, randomised clinical trial Elaine MacHale, Garrett Greene, Christopher Mulvey, The Lancet Respiratory Medicine AsthmaChronic Disease ManagementMedication AdherenceDigital HealthDigital Measurement	2023	53
Benralizumab after sub‐optimal response to mepolizumab in severe eosinophilic asthma Joanne Kavanagh, A Hearn, G d’Ancona, Allergy AsthmaClinical ImmunologyInflammatory Lung DiseaseLung InflammationAllergy Medicine	2020	44
Real-World Effectiveness of Anti–IL-5/5R Therapy in Severe Atopic Eosinophilic Asthma with Fungal Sensitization Jaideep Dhariwal, A Hearn, Joanne Kavanagh, The Journal of Allergy and Clinical Immunology In Practice AsthmaAllergyReal-world EffectivenessAllergy MedicineImmunology	2021	40
Steroid-sparing effects of benralizumab in patients with eosinophilic granulomatosis with polyangiitis Alexandra M. Nanzer, Jaideep Dhariwal, Joanne Kavanagh, ERJ Open Research	2020	37
Prescribing Patterns and Treatment Adherence in Patients with Asthma During the COVID-19 Pandemic Hetal Dhruve, G d’Ancona, Steven M. Holmes, The Journal of Allergy and Clinical Immunology In Practice AsthmaDisease ManagementPreventive MedicineTreatment And PreventionCovid-19 Pandemic	2021	37

Page 1